Drug Trials Snapshot - LUPKYNIS

A new DRUG TRIALS SNAPSHOT is now available. LUPKYNIS is a drug used to treat patients with active lupus nephritis. Lupus nephritis (LN) is an inflammation of the kidneys that is caused by systemic lupus erythematous (SLE) - a chronic, autoimmune disease. LUPKYNIS is a capsule that is taken twice daily by mouth in combination with two other drugs (mycophenolate mofetil and corticosteroid).   See more Drug Trials Snapshots or contact us with questions at Snapshots@fda.hhs.gov     Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA